Lactobacillus reuteri for Health & Longevity - Quick Reference Sheet

Lactobacillus reuteri for Health & Longevity

Created on 07/15/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

A gut-friendly bacterium with dependable human evidence for healthier gums, faster recovery from digestive infections, calmer colic in breastfed infants, and, for one specific form, modestly lower cholesterol. Bone, mood, and skin signals remain thin. The headline longevity and hormone claims come almost entirely from animals. Effects are tied to the exact strain, and it is generally well tolerated. (Full Review)

Protocol

Standard Dose
~1×10⁸ CFU once daily
DSM 17938 drops or tablets for general gut and immune health; most conservative, best-tolerated approach
Cholesterol Regimen
~2.9×10⁹ CFU twice daily
NCIMB 30242 strain for lipid effects, studied as a twice-daily split dose
Timing & Continuity
With or after a meal
Buffers stomach acid; daily dosing needed as it clears within days to about two weeks
Time to effect
Digestive & Colic
Days to ~3 weeks
Digestive and colic effects appear soonest
Cholesterol
6–9 weeks
Typical time for cholesterol changes
Bone
Many months
Bone effects require prolonged continuous use

Benefits

Contraindications
  • Severe immunocompromise
  • Chemotherapy
  • Critical illness or intensive care
  • Central venous catheter
  • Short bowel syndrome
  • Severe acute pancreatitis
  • Prosthetic heart valves or history of infective endocarditis
  • Premature infants outside medical supervision
Key Interactions
  • Antibiotics (amoxicillin, ciprofloxacin, metronidazole)
  • Antidiarrheal and antacid agents (loperamide)
  • Other probiotics and prebiotics
  • Cholesterol-lowering supplements and drugs (plant sterols, berberine, soluble fiber, statins)

Risk & Side Effects

  • High: Transient digestive symptoms
  • Medium: Bacteremia and systemic infection in vulnerable hosts; D-lactate production in short bowel contexts
  • Low: Histamine-related reactions; overgrowth symptoms from high-CFU home ferments
  • Speculative: Long-term effects of very-high-dose homemade yogurt; consequences of product mislabeling or strain substitution

Monitoring

Marker Target Why
Total cholesterol <180 mg/dL Tracks response to cholesterol-lowering strains
LDL cholesterol <100 mg/dL Main artery-clogging cholesterol targeted by NCIMB 30242
Apolipoprotein B <80 mg/dL Counts cholesterol-carrying particles, a sharper risk marker than LDL alone
hs-CRP <1.0 mg/L Gauges body-wide inflammation the microbe may lower
25-hydroxyvitamin D 40–60 ng/mL May rise with NCIMB 30242; supports bone and immunity

Cadence: Recheck lipids and inflammation at about 8–12 weeks, then every 6–12 months; assess vitamin D and any bone markers every 6–12 months

Qualitative Assessment

  • Digestive comfort and bloating
  • Bowel regularity and stool form
  • Energy levels through the day
  • Sleep quality
  • Skin appearance and any dermatitis
  • Mood and stress resilience
  • Gum health and breath (for oral-health strains)